Oncobiologics (OTLK)
(Delayed Data from NSDQ)
$0.96 USD
-0.03 (-2.73%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.97 +0.01 (0.73%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Oncobiologics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
OTLK 0.96 -0.03(-2.73%)
Will OTLK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for OTLK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OTLK
OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug
Oncobiologics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates
OTLK: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for July 30th
OTLK Stock Falls on Failure to Meet Non-Inferiority Goal in AMD Study
Other News for OTLK
OTLK forms MACD Bullish Signal Line Cross on September 20
OTLK forms Narrow Range Bar on September 19
OTLK forms NR7 on September 17
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names